Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Founder Pharma, a core subsidiary of the Peking University Founder Group, is a comprehensive pharmaceutical enterprise integrated with research, development, production, and sales. The company focuses on a wide range of therapeutic areas including endocrine disorders, cardiovascular diseases, and anti-infectives, leveraging its strong ties to Peking University for academic and clinical research. Its product portfolio includes both chemical drugs and traditional Chinese medicines, with a significant emphasis on treatments for chronic conditions like diabetes and hypertension. Founder Pharma operates several manufacturing bases and research institutes across China, positioning itself as a key player in the domestic pharmaceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Founder Pharmaceutical Research.